"95% Efficacy" for US Pfizer Vaccine Apply for Emergency Use Permission November 19, 6:20
k10012719851_202011190619_202011190619.mp4
Pfizer, an American pharmaceutical giant, announced on the 18th the final analysis result on the effect of the new coronavirus vaccine under development, which is said to be 95% effective, and within a few days FDA = America We are applying to the Food and Drug Administration for an emergency use permit.
On the 18th, American pharmaceutical giant Pfizer announced the final analysis of the vaccine's effectiveness in clinical trials regarding the vaccine it is developing with the German company Biontech.
According to this, 170 out of more than 40,000 people in clinical trials became infected with the new coronavirus.
Of these, 8 were vaccinated, while 162 were vaccinated with a placebo called "placebo," which means that the vaccine is 95% effective. It is said that it was.
There were 10 cases of severe illness, but 1 in the vaccinated group and 9 in the placebo group.
Pfizer says no serious safety concerns have been reported to vaccinated people, but 3.8% had malaise and 2% had headaches after the second vaccination. And so on.
Pfizer then told the FDA in the next few days that the drug under development would be available for limited use before formal approval, saying it had safety data. I am applying for permission.
Once the application is made, the FDA will consult with a committee of experts to decide whether to give permission, but FDA executives told local media that the review would "take weeks". I'm talking.
The Japanese government has basically agreed to supply Pfizer vaccine for 60 million people by the end of June next year.